Publicaciones en colaboración con investigadores/as de Hospital Infanta Leonor (7)

2022

  1. A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma

    Blood cancer journal, Vol. 12, Núm. 4, pp. 68

  2. The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies

    Biomarker Research, Vol. 10, Núm. 1

2021

  1. Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 6, pp. 413-420

  2. The current role of the heavy/light chain assay in the diagnosis, prognosis and monitoring of multiple myeloma: An evidence-based approach

    Diagnostics, Vol. 11, Núm. 11

2020

  1. Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality

    Blood Cancer Journal, Vol. 10, Núm. 10

2019

  1. Timing treatment for smoldering myeloma: is earlier better?

    Expert Review of Hematology, Vol. 12, Núm. 5, pp. 345-354

2015

  1. Gammapatías biclonales: ¿un significado clínico diferente?

    Revista Clinica Espanola